外科理论与实践 ›› 2025, Vol. 30 ›› Issue (06): 469-473.doi: 10.16139/j.1007-9610.2025.06.02
收稿日期:2025-08-04
出版日期:2025-11-25
发布日期:2026-01-26
通讯作者:
蒋奎荣,E-mail: jiangkuirong@njmu.edu.cn基金资助:Received:2025-08-04
Online:2025-11-25
Published:2026-01-26
摘要:
随着外科技术进步及新辅助治疗、转化治疗的应用,联合动脉切除与重建的手术为局部晚期胰腺癌病人提供了潜在的治愈可能。术前通过影像学精细评估动脉受累情况,结合生物学指标及病人体能状况严格筛选病例。术中可采用“动脉优先入路”及“动脉鞘剥除”等策略,判断是否可行根治性切除。对于无法剥离的动脉侵犯,可根据受累部位行腹腔干切除、肝动脉切除或肠系膜上动脉切除重建等术式。因动脉切除技术复杂,并发症发生率及死亡率高,故该手术应在具备丰富经验的高容量胰腺中心开展,并继续通过大样本研究进一步验证其远期疗效。
中图分类号:
尹杰, 蒋奎荣. 动脉切除在胰腺癌根治术中的应用体会[J]. 外科理论与实践, 2025, 30(06): 469-473.
YIN Jie, JIANG Kuirong. Clinical experience with arterial resection during radical resection for pancreatic cancer[J]. Journal of Surgery Concepts & Practice, 2025, 30(06): 469-473.
| [1] | SIEGEL R L, GIAQUINTO A N, JEMAL A. Cancer statistics,2024[J]. CA Cancer J Clin, 2024, 74(1):12-49. |
| [2] |
STROBEL O, NEOPTOLEMOS J, JÄGER D, et al. Optimizing the outcomes of pancreatic cancer surgery[J]. Nat Rev Clin Oncol, 2019, 16(1):11-26.
doi: 10.1038/s41571-018-0112-1 pmid: 30341417 |
| [3] |
YONKUS J A, ALVA-RUIZ R, COLGLAZIER J J, et al. Outcomes of visceral arterial interposition graft reconstruction for locally advanced pancreatic cancer[J]. Ann Surg, 2025, 281(6):1006-1014.
doi: 10.1097/SLA.0000000000006350 URL |
| [4] |
LOOS M, KESTER T, KLAIBER U, et al. Arterial resection in pancreatic cancer surgery: effective after a learning curve[J]. Ann Surg, 2022, 275(4):759-768.
doi: 10.1097/SLA.0000000000004054 URL |
| [5] |
XUE K, HUANG X, ZHAO P, et al. Perioperative and long-term survival outcomes of pancreatectomy with arterial resection in borderline resectable or locally advanced pancreatic cancer following neoadjuvant therapy: a systematic review and meta-analysis[J]. Int J Surg, 2023, 109(12):4309-4321.
doi: 10.1097/JS9.0000000000000742 pmid: 38259002 |
| [6] |
MOLLBERG N, RAHBARI N N, KOCH M, et al. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis[J]. Ann Surg, 2011, 254(6):882-893.
doi: 10.1097/SLA.0b013e31823ac299 pmid: 22064622 |
| [7] |
FORTNER J G, KIM D K, CUBILLA A, et al. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection[J]. Ann Surg, 1977, 186(1):42-50.
pmid: 195543 |
| [8] |
APPLEBY L H. The coeliac axis in the expansion of the operation for gastric carcinoma[J]. Cancer, 1953, 6(4):704-707.
doi: 10.1002/1097-0142(195307)6:4<704::aid-cncr2820060410>3.0.co;2-p pmid: 13059764 |
| [9] |
SCHNEIDER M, HACKERT T, STROBEL O, et al. Technical advances in surgery for pancreatic cancer[J]. Br J Surg, 2021, 108(7):777-785.
doi: 10.1093/bjs/znab133 URL |
| [10] |
NAPOLI N, KAUFFMANN E F, LOMBARDO C, et al. Postoperative results, learning curve, and outcomes of pancreatectomy with arterial resection: a single-center retrospective cohort study on 236 procedures[J]. Int J Surg, 2024, 110(10):6111-6125.
doi: 10.1097/JS9.0000000000000971 URL |
| [11] | 黄徐敏, 张凯, 吴鹏飞, 等. 联合动脉切除胰腺癌根治术单中心回顾性分析[J]. 中华普通外科杂志, 2025, 40(3):188-194. |
| HUANG X M, ZHANG K, WU P F, et al. Arterial resection in pancreatic cancer surgery: a single-center review on 135 procedures[J]. Chin J Gen Surg, 2025, 40(3):188-194. | |
| [12] |
XU Y C, YANG F, FU D L. Clinical significance of variant hepatic artery in pancreatic resection: a comprehensive review[J]. World J Gastroenterol, 2022, 28(19):2057-2075.
doi: 10.3748/wjg.v28.i19.2057 URL |
| [13] |
BOLM L, PISUCHPEN N, QADAN M, et al. Prediction of R status in resections for pancreatic cancer using simplified radiological criteria[J]. Ann Surg, 2022, 276(2):215-221.
doi: 10.1097/SLA.0000000000005433 pmid: 36036988 |
| [14] |
HABIB J R, KINNY-KÖSTER B, VAN OOSTEN F, et al. Periadventitial dissection of the superior mesenteric artery for locally advanced pancreatic cancer: surgical planning with the "halo sign" and "string sign"[J]. Surgery, 2021, 169(5):1026-1031.
doi: 10.1016/j.surg.2020.08.031 URL |
| [15] |
GARNIER J, GARG K, LEVINE J, et al. Two-stage Mayo clinic class Ⅲb celiac axis resection for pancreatic adenocarcinoma: stepwise management[J]. Ann Surg Oncol, 2025, 32(4):2476-2478.
doi: 10.1245/s10434-024-16673-z |
| [16] |
SEELEN L W F, DOPPENBERG D, STOOP T F, et al. Minimum and optimal CA19-9 response after two months induction chemotherapy in patients with locally advanced pancreatic cancer: a nationwide multicenter study[J]. Ann Surg, 2024, 279(5):832-841.
doi: 10.1097/SLA.0000000000006021 URL |
| [17] |
TSAI S, GEORGE B, WITTMANN D, et al. Importance of normalization of CA19-9 levels following neoadjuvant therapy in patients with localized pancreatic cancer[J]. Ann Surg, 2020, 271(4):740-747.
doi: 10.1097/SLA.0000000000003049 pmid: 30312198 |
| [18] |
IRONSIDE N, BARRETO S G, LOVEDAY B, et al. Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival[J]. Br J Surg, 2018, 105(6):628-636.
doi: 10.1002/bjs.10832 URL |
| [19] |
INOUE Y, SAIURA A, OBA A, et al. Optimal extent of superior mesenteric artery dissection during pancreaticoduodenectomy for pancreatic cancer: balancing surgical and oncological safety[J]. J Gastrointest Surg, 2019, 23(7):1373-1383.
doi: 10.1007/s11605-018-3995-3 pmid: 30306451 |
| [20] |
NELSON D W, BLANCHARD T H, CAUSEY M W, et al. Examining the accuracy and clinical usefulness of intraoperative frozen section analysis in the management of pancreatic lesions[J]. Am J Surg, 2013, 205(5):613-617.
doi: 10.1016/j.amjsurg.2013.01.015 pmid: 23592172 |
| [21] |
BOGGI U, KAUFFMANN E, NAPOLI N, et al. Rediscover international guidelines on the perioperative care of surgical patients with borderline-resectable and locally advanced pancreatic cancer[J]. Ann Surg, 2024, 280(1):56-65.
doi: 10.1097/SLA.0000000000006248 pmid: 38407228 |
| [22] |
LOOS M, KHAJEH E, MEHRABI A, et al. Distal pancreatectomy with en bloc celiac axis resection (DP-CAR) for locally advanced pancreatic cancer: a safe and effective procedure[J]. Ann Surg, 2023, 278(6):e1210-e1215.
doi: 10.1097/SLA.0000000000005866 URL |
| [23] | 黄徐敏, 张凯, 尹杰, 等. 联合腹腔干切除的胰体尾癌根治术治疗胰颈体癌的单中心回顾性分析[J]. 中华外科杂志, 2023, 61(10):894-900. |
| HUANG X M, ZHANG K, YIN J, et al. Distal pancreatectomy with celiac axis resection for pancreatic body cancer: a single center review of 89 consecutive cases[J]. Chin J Surg, 2023, 61(10):894-900. | |
| [24] |
HACKERT T, WEITZ J, BÜCHLER M W. Splenic artery use for arterial reconstruction in pancreatic surgery[J]. Langenbecks Arch Surg, 2014, 399(5):667-671.
doi: 10.1007/s00423-014-1200-z URL |
| [25] |
KLAIBER U, MIHALJEVIC A, HACKERT T. Radical pancreatic cancer surgery-with arterial resection[J]. Transl Gastroenterol Hepatol, 2019, 4:8.
doi: 10.21037/tgh.2019.01.07 pmid: 30976711 |
| [1] | 温晨磊, 邹思奕, 李凡露, 詹茜, 沈柏用. 《胰腺导管腺癌系统治疗亚洲专家共识》解读[J]. 外科理论与实践, 2025, 30(06): 461-468. |
| [2] | 康晓超, 李轶楷, 郭世伟, 金钢. 胰腺癌新辅助治疗若干问题思考:从循证医学到精准医疗的范式转换[J]. 外科理论与实践, 2025, 30(06): 474-478. |
| [3] | 毛谅, 仇毓东. 人工智能在胰腺癌术前诊断中的应用进展[J]. 外科理论与实践, 2025, 30(06): 479-482. |
| [4] | 杨峰, 徐业成, 傅德良. 胰头肿瘤精准剜除的技术革新与术后胰瘘防控策略[J]. 外科理论与实践, 2025, 30(06): 488-493. |
| [5] | 徐琬倩, 周春华, 邹多武. 消化内镜在胰腺导管内乳头状黏液性肿瘤诊疗中的应用及进展[J]. 外科理论与实践, 2025, 30(05): 369-377. |
| [6] | 计蓓, 商正晔, 庹必光, 刘雪梅. 功能性胰腺神经内分泌肿瘤综合诊治策略(附3例报告)[J]. 外科理论与实践, 2025, 30(05): 438-443. |
| [7] | 金佳斌, 马君俊, 叶枫, 马诗瑜, 陈敬贤. 基于网络药理学、分子对接和双样本孟德尔随机化分析探讨槐耳抗胰腺癌的作用机制[J]. 外科理论与实践, 2025, 30(03): 247-255. |
| [8] | 苏秉蔚 综述, 沈柏用 审校. 胰腺导管腺癌病人循环免疫及肿瘤微环境中T细胞亚群异常[J]. 外科理论与实践, 2025, 30(02): 171-175. |
| [9] | 李景峰, 施昱晟, 邓侠兴, 彭承宏, 沈柏用. 国产多孔机器人手术系统在胰腺外科临床应用中的发展[J]. 外科理论与实践, 2025, 30(01): 70-73. |
| [10] | 徐荆庶, 施建华, 顾海雁, 陈蕾, 钱孝琳, 陆璐, 钮登. 1992—2021年上海市徐汇区户籍居民胰腺癌死亡率趋势分析[J]. 外科理论与实践, 2025, 30(01): 34-40. |
| [11] | 陆忠晓, 汤杰, 黄文海. 以SEER为基础的列线图构建和胰腺癌病人生存预测[J]. 外科理论与实践, 2024, 29(01): 46-53. |
| [12] | 王美文, 傅宁稹, 王伟珅, 任新平. 胰十二指肠联合静脉切除重建术后早期血管栓塞的床旁超声诊断及危险因素分析[J]. 外科理论与实践, 2024, 29(01): 54-60. |
| [13] | 王婷, 王朝夫, 袁菲. 胰腺导管内乳头状黏液性肿瘤的病理诊断进展[J]. 外科理论与实践, 2024, 29(01): 67-73. |
| [14] | 郭宇杰, 唐颖, 顾季春, 杨峰, 刘华晔, 金忱, 傅德良, 李骥. 单纯切除胰腺实性假乳头状瘤的临床价值分析[J]. 外科理论与实践, 2024, 29(01): 27-33. |
| [15] | 华杰, 施思, 孟庆才, 许航, 刘江, 梁晨, 王巍. 改良“双U法胰肠吻合”在胰十二指肠切除术的运用及效果评估[J]. 外科理论与实践, 2024, 29(01): 34-39. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
